about
Current concepts of shared decision making in orthopedic surgery.Comparing the Incidence and Clinical Data for Simultaneous Bilateral Versus Unilateral Total Hip Arthroplasty in New York State Between 1990 and 2010.The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty.Staphylococcus aureus Decolonization Protocol Decreases Surgical Site Infections for Total Joint ReplacementThe use of a multiplanar, multi-axis external fixator to achieve knee arthrodesis in a worst case scenario: a case seriesPerioperative strategies for decreasing infection: a comprehensive evidence-based approach.Athletic participation after hip and knee arthroplasty.Blood, bugs, and motion - what do we really know in regard to total joint arthroplasty?Basic principles for conducting human research in orthopaedic medicine.High-performance total knee replacement.Hip dysplasia in the skeletally mature patient.Single Institution Early Experience with the Bundled Payments for Care Improvement Initiative.2014 Austrian-Swiss-German Fellowship.Impact of Social Support and Pain Coping Abilityon Length of Stay and Discharge Disposition following Hip and Knee Arthroplasty A Prospective Study.Incidence and Risk Factors for Blood Transfusion in Total Joint Arthroplasty: Analysis of a Statewide Database.Implementation of Bundled Payment Initiatives for Total Joint Arthroplasty: Decreasing Cost and Increasing Quality.What is the Best Strategy to Minimize After-Care Costs for Total Joint Arthroplasty in a Bundled Payment Environment?Feasibility of integrating standardized patient-reported outcomes in orthopedic care.The use of the Risk Assessment and Prediction Tool in surgical patients in a bundled payment program.The effect of severity of illness on total joint arthroplasty costs across New York state hospitals: an analysis of 172,738 cases.Improvement in Total Joint Replacement Quality Metrics: Year One Versus Year Three of the Bundled Payments for Care Improvement Initiative.Variation in Diagnoses for Hip Arthroplasty Among New York State Hospitals: Implications for the Comprehensive Care for Joint Replacement Model.A Randomized, Double-Blind, Placebo-Controlled Study of Neuromuscular Electrical Stimulation (NMES) use for Recovery after Elective Total Hip Replacement Surgery.Disparities in Discharge Destination After Lower Extremity Joint Arthroplasty: Analysis of 7924 Patients in an Urban Setting.The Etiology of Improved Outcomes at High Volume Centers Learning Theory and the Case of Implant Flashing.Association of Depression With 90-Day Hospital Readmission After Total Joint Arthroplasty.Orthopedic Implant Waste: Analysis and Quantification.Etiology of Readmissions Following Orthopaedic Procedures and Medical Admissions. A Comparative Analysis.Early Results of Medicare's Bundled Payment Initiative for a 90-Day Total Joint Arthroplasty Episode of Care.You Want a Successful Bundle: What About Post-discharge Care?Cost Analysis of Total Joint Arthroplasty Readmissions in a Bundled Payment Care Improvement Initiative.Prior Staphylococcus Aureus Nasal Colonization: A Risk Factor for Surgical Site Infections Following Decolonization.Survivorship and Complications of Revision Total Hip Arthroplasty with a Mid-Modular Femoral Stem.Role of Sociodemographic, Co-morbid and Intraoperative Factors in Length of Stay Following Primary Total Hip Arthroplasty.Principles of Antibiotic Prophylaxis in Total Joint Arthroplasty: Current Concepts.Risk Factors for Infection Following Total Knee Arthroplasty: A Series of 3836 Cases from One Institution.Is routine antibiotic prophylaxis cost effective for total joint replacement patients?Periprosthetic Joint Infection in Patients Receiving TNFα Antagonists.The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA).Recurrent hemarthrosis in a hemophilic patient after revision total knee arthroplasty.
P50
Q30400272-9CA18B22-B979-4903-87EF-A2FCF9A09FC1Q30975542-98949564-C604-43E0-AF83-CB6F0078AD72Q34962954-EC30C554-0243-4CD4-A6A5-BA3EB8BBC126Q35430091-cd5761cf-442d-1874-30f4-7d0fe9af9860Q37109155-9DB6F8D1-0BBE-494B-B341-0223A816C095Q37736434-F276F30A-D42F-4F9B-B3C7-A5316CB5D3FFQ37772936-CC367A25-35B3-410D-B782-7FC486A9F268Q37844589-c615bab9-4b0b-89eb-5612-37b2e24fa6c7Q38111274-80EEEB7D-CB6A-4288-9FD8-9C19CB51D536Q38137153-43B1BCAA-2119-45CF-B861-12422CFB3643Q38242509-429FE2CA-4D5E-4F9D-98CD-FB3D00A966B0Q38374400-A3EB16AB-46B8-4A50-AF4C-4C550FF646A1Q38423040-245842AE-3854-43FD-8BB1-4C893E127DABQ38742834-C5A2DBE8-896D-4B14-A2E8-F72A2A26C336Q38745617-524BB6B0-F29B-4070-8C2F-BA58A8FEEAA3Q38799266-1EFDF8B9-9FD1-4EEC-B7EC-C7507B94F2DBQ38848510-3C45BFA8-AC21-4B7C-ABF2-444133A86931Q38936722-530C5219-B7FF-4E91-BA43-7A1C90B3DDD3Q39051989-EE811EED-202F-4316-B2E2-BBAE19D64BB8Q39120939-5F97145B-9B08-404C-B65D-5947C2218AC9Q39123789-DC28188C-1D22-4B05-BD78-72824ACEBFF8Q39129128-768F707E-1332-4B97-BDDA-10D63F60235BQ39213189-3432C585-7CFD-4C0B-8544-69D7DB486B4AQ39631717-D23BBF16-8039-459A-BD57-2097E1E6C7EEQ39696638-A95096FF-4F61-4BD6-84C6-BC0B3EE4AA19Q39745308-23E15085-9614-4965-9181-1F78FD2B1E0EQ40213823-6C207895-74F2-4876-ADBB-975BA725FCE8Q40249144-A4E0DDBF-2FB9-4C0D-A733-0BDB75A45D67Q40318866-0CF2B87B-4F93-4A9B-B271-71BD9E773F3CQ40363611-14048412-9C7E-45D8-86EE-5B77264CA4F2Q40368725-A3AA205A-870B-4867-807F-27B2B2BA470BQ40457453-7BFB519E-E435-480B-A22B-17E83D8A30B4Q40684896-481772AD-ECB6-430C-9484-EA6B9D8DF489Q40719571-3923C478-7507-4B81-B700-79C0E01AFC26Q40726821-F6DA3EF8-8F4E-4921-BE86-41877EB1E46BQ41102251-8D042F10-2E34-41CD-B92F-08E55DD9BA12Q41611834-9a45a3e3-4f9c-f719-84d5-187f234e8652Q42235287-5F15BF9A-FA34-41A4-8375-6A98AFC2708AQ42658555-227FADC4-F36E-4382-BEE3-951E61653277Q42855859-7E7DE8D0-4537-42CF-AFE2-5D61464BC9CF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
James D Slover
@en
James D Slover
@nl
type
label
James D Slover
@en
James D Slover
@nl
prefLabel
James D Slover
@en
James D Slover
@nl
P31
P496
0000-0003-0099-0721